APPLICATION
NDA202212
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
TABLET, FOR SUSPENSION
MARKETING STATUS
None (Tentative Approval)
Products
NEVIRAPINENone (Tentative Approval)
NEVIRAPINE 100MG · TABLET, FOR SUSPENSION · ORAL
NEVIRAPINENone (Tentative Approval)
NEVIRAPINE 50MG · TABLET, FOR SUSPENSION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.